Joinn Laboratories(China)Co.,Ltd. (603127.SS)

CNY 17.42

(0.87%)

Market Cap (In CNY)

11.92 Billion

Revenue (In CNY)

2.37 Billion

Net Income (In CNY)

396.99 Million

Avg. Volume

12.3 Million

Currency
CNY
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
12.32-24.31
PE
-
EPS
-
Beta Value
0.655
ISIN
CNE100002W27
CUSIP
-
CIK
-
Shares
-
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Dr. Yuxia Feng M.D.
Employee Count
-
Website
https://www.joinn-lab.com
Ipo Date
2017-08-25
Details
Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People's Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase I clinical research units, and bioanalytical services. The Sales of Research Models segment designs, produces, breeds, and sells research models, non-human primates, and rodents. The company also offers investment management and cell-based assay (CBA) services. Joinn Laboratories(China)Co.,Ltd. was founded in 1995 and is headquartered in Beijing, China.